用于核和线粒体双重向抗瘤治疗的光活性单功能Pt(ii) - 氨酸复合体
Ting He1, Qiaoju Ren1, Yu Zhang1
1Marshall Laboratory of Biomedical Engineering, International Cancer Center, Laboratory of Evolutionary Theranostics (LET), School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University Shenzhen 518055 China jingl@szu.edu.cn.
Chemical science
|July 23, 2025
概括
研究人员开发了一种新型的光活性金-氨酸染料复合物,用于双重向的癌症治疗. 这种新的 (Pt) 药物克服了耐药性并降低了毒性,为基于Pt的治疗提供了更好的疗效和安全性.
科学领域:
- 药用化学 医学化学
- 癌症生物学 癌症生物学
- 纳米技术 纳米技术
背景情况:
- 单功能 (Pt) 复合物为传统的Pt药物提供了替代品,有可能克服耐药性并降低毒性.
- 然而,单功能Pt复合物往往具有有限的抗瘤疗效.
- 开发有针对性的疗法对于改善癌症治疗结果至关重要.
研究的目的:
- 开发一种光活性单功能Pt(ii) - 氨酸染料复合物,用于双重向的抗瘤治疗.
- 提高基于的化疗药物的疗效和安全性.
- 在体内调查复合物的准能力和治疗潜力.
主要方法:
- 一种新型Pt(ii) - 氨酸染料复合物 (Pt-CDPEN) 的合成和表征.
- 对光物理性质的评估,包括单个氧量子产量.
- 对细胞毒性的评估,IC50值和溶酶体逃逸特性.
- 在体内对PEGylated Pt-CDPEN (LET-9) 进行瘤积累,抗瘤疗效和生物相容性的研究.
主要成果:
- 与原始氨酸染料相比,Pt-CDPEN的单氧量子产量是2.1倍的.
- 光活化Pt-CDPEN的IC50比西斯丁低16倍以上.
- 综合体证明了溶酶体逃逸,使核和线粒体的双重向成为可能.
- 基化Pt-CDPEN (LET-9) 显示出高瘤积累,高效的抗瘤活性,以及体内良好的生物相容性.
结论:
- 开发的Pt(ii) - 氨酸单功能复合体是双向抗瘤治疗的有希望的平台.
- 这种方法有效地减轻化疗耐药性,减少全身毒性.
- 这项研究突出了提高基癌症治疗疗法的疗效和安全性的新策略.
更多相关视频
08:03Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
9.1K
11:04An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
3.2K
相关概念视频
01:46Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K